Manufacturer record
Shri hari Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Shri hari Pharmaceuticals (Gujarat) were declared Not of Standard Quality between January 2020 and April 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: S24B045, Dextromethorphan HBr, Phenylephrine HCl & Chlorpheniramine Maleate Syrup (DEX HS Syrup) (exp Jan 2026). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay of Dextromethorph an Hydrobromide. Listed in the April 2024 alert.
Records by type
2 records linked to Shri hari Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dextromethorphan HBr, Phenylephrine HCl & Chlorpheniramine Maleate Syrup (DEX HS Syrup) | Batch S24B045Mfg Feb 2024 · Exp Jan 2026 | Assay of Dextromethorph an HydrobromideAssay | CDL KolkataCDSCO lab | Apr 2024 |
| Radin Syrup (Ranitidine Oral Solution I.P.) | Batch S18J025Mfg Oct 2018 · Exp Sep 2020 | AssayAssay | RDTL GuwahatiState lab | Jan 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.